Molecular genetics of C1 inhibitor

Immunobiology

Volumn 199, Issue 2, 1998, Pages 358-365

  Tosi, Mario ^a,b  

^a INSTITUT PASTEUR   (France)

^b NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENT COMPONENT C1S INHIBITOR; MESSENGER RNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANGIONEUROTIC EDEMA; ARTICLE; COMPLEMENT DISORDER; EXON; FAMILY HISTORY; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE MUTATION; HORMONAL REGULATION; HUMAN; INTRACELLULAR TRANSPORT; INTRON; MISSENSE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STOP CODON;

EID: 0031712910     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(98)80040-5     Document Type: Article

References (23)

1. STOPPA-LYONNET, D., M. TOSI, J. LAURENT, A. SOBEL, G. LAGRUE, and T. MEO. 1987. Altered C1 inhibitor genes in type I hereditary angioedema. New Engl. J. Med. 317: 1-6.
2. TOSI, M. 1993. Molecular genetics of C1-inhibitor and hereditary angio-oedema. In Complement in Health and Disease, second edition vol. K. WHALEY, M. LOSS and J. M. WEILER. p. 245-267.
3. DONALDSON, V. H. 1989. C1-inhibitor and its genetic alterations in hereditary angio-neurotic edema. Intern. Rev. Immunol. 10: 1-16.
4. DAVIS, A. 1989. Hereditary and acquired deficiencies of C1 inhibitor. Immunodeficiency Rev. 1: 207-226.
5. VERPY, E., M. BIASOTTO, M. BRAI, G. MISIANO, T. MEO, and M. TOSI. 1996. Exhaustive mutation scanning of the C1 inhibitor gene reveals new genotype-phenotype correlations in angioedema. Am. J. Hum. Genet. 59: 308-319.
6. CARTER, P. E., C. DUPONCHEL, M. TOSI, and J. E. FOTHERGILL. 1991. Complete nucleotide sequence for the C1 inhibitor with an unusually high density of Alu elements. Eur. J. Biochem. 197: 301-308.
7. STOPPA-LYONNET, D., P. E. CARTER, T. MEO, and M. TOSI. 1990. Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements. Proc. Natl. Acad. Sci. USA 87: 1551-1555.
8. ARIGA, T., P. E. CARTER, and A. E. DAVIS III. 1990. Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene. Genomics 8: 607-613.
9. BISSLER, J., F. ROSEN, M. CICARDI, R. HARRISON, and A. 3. DAVIS. 1997. Molecular defects in hereditary angioneurotic edema. Proc. Assoc. Am. Physi. 109: 164-173.
10. VERPY, E., M. BIASOTTO, T. MEO, and M. TOSI. 1994. Efficient detection of point mutations on color-codedstrands of target DNA. Proc. Natl. Acad. Sci. USA 91: 1873-1877.
11. DAVIS, A. III, J. BISSLER, and M. CICARDI. 1993. Mutations in the C1 inhibitor gene that result in Hereditary Angioneurotic Edema. Behring Inst. Mitt. 93: 313-320.
12. BISSLER, J. J., V. H. DONALDSON, and A. E. DAVIS III. 1994. Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema. Hum. Genet. 93: 265-269.
13. BISSLER, J., M. CICARDI, V. DONALDSON, P. GATENBY, F. ROSEN, A. SHEFFER, and A. DAVIS III. 1994. A cluster of mutations within a short triplet repeat in the C1 inhibitor gene. Proc. Natl. Acad. Sci. USA 91: 9622-9625.
14. RUSSELL, J. A., WHALEY, K., and HEAPHY, S. 1997. The sequence of a cDNA encoding functional murine C1-inhibitor protein. Biochimica et Biophysica Acta 1352: 156-160.
15. STEIN, P. E., and R. W. CARRELL. 1995. What do dysfunctional serpins tell us about molecular mobility and disease. Nature Struc. Biol. 2: 96-113.
16. VERPY, E. 1995. Crucial residues in the Carboxy-terminal End of C1 inhibitor Revealed by Pathogenic Mutants Impaired in Secretion or Function. J. Clin. Invest. 95: 350-359.
17. ELDERING, E., E. VERPY, D. ROEM, T. MEO, and M. TOSI. 1995. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. J. Biol. Chem. 270: 2579-2587.
18. LACHMANN, P. J., and F. S. ROSEN. 1984. The catabolism of C1-inhibitor and the pathogenesis of hereditary angio-edema. Acta Pathol. Microbiol. Immunol. Scand. 284: 35-39.
19. KRAMER, J., F. S. ROSEN, H. R. COLTEN, K. RAJCZY, and R. C. STRUNK. 1993. Transinhibition of C1 inhibitor net synthesis in type I hereditary angioneurotic edema. J. Clin. Invest. 91: 1258-1262.
20. ERNST, S., A. CIRCOLO, A. DAVIS, K. GHEESLING-MULLIS, M. FLIESLER, and R. STRUNK. 1996. Impaired production of both normal and mutant C1 inhibitor proteins in type I hereditary angioedema with duplication in exon 8. J. Immunol. 157: 405-410.
21. ZAHEDI, K., A. E. PRADA, and A. E. DAVIS III. 1994. Transcriptional regulation of the C1 inhibitor gene by γ-interferon. J. Biol. Chem. 269: 9669-9674.
22. VINCI, G., TOSI, M., DUPONCHEL, C., LENER, M., and T. MEO. 1996. Expression and induction studies of the human C1-INH gene in transgenic mice. Mol. Immunol.
23. VINCI, G., DUPONCHEL, C., LENER, M., TOSIE, M., and T. MEO. 1997. Testosterone does not affect expression of C1 inhibitor from either the endogeneous or the human C1 INH gene in transgenic mice. 6th European Meeting on Complement and Human Disease. Exp. Clin. Immunogenet. 14: 30.